Vittorio Pengo M.D. (CV as of April 2014)

Vittorio Pengo M.D. (CV as of April 2014)
Professor of Cardiovascular Medicine, Department of Cardiac Thoracic and Vascular
Sciences, and Director of Thrombosis Center, University of Padova School of Medicine,
Padova Italy
Mailing Address: Clinical Cardiology, Thrombosis Center, via Giustiniani 2, 35128 Padova
Italy
M.D. degree
University of Padova 1974
Residency
Internal Medicine, University of Padova
Certification
Internal Medicine 1980
Cardiology 1985
Post Graduate training
Clinical Medicine 1974-1983
Research Fellow, Cardeza Foundation,
Philadelphia, PA, USA 1984-1985
Visiting scientist, Cardeza Foundation,
Philadelphia, PA, USA, 1988
Clinical Cardiology 1988-
Clinical Interests
Primary/secondary prevention and
treatment of venous and arterial
thromboembolism
Research Interests
Pathophysiology and treatment of
thrombosis
Reviwer for the following Journals:
New England Journal of Medicine, Circulation, Lancet, Blood, Journal of Thrombosis and Haemostasis,
Thrombosis and Haemostasis, Thrombosis Research, American Journal of Cardiology, Haematologica,
American Journal of Hematology, Journal of Cardiovascular Medicine, European Journal of Clinical
Investigation, European Journal of Internal Medicine, Canadian Medical Association Journal
Associate Editor of Internal and Emergency Journal since 2011
235 original papers in International Journals (Pub Med)
Total Citations: >8000 and H index: 44 (Scopus).
Padua, September 4, 2014
1
Major Publications
Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russel Viper Venom Time for
the diagnosis of the lupus anticoagulant.
Blood 1986;68:869-74.
Pengo V, Thiagarajan P, Heine M, Shapiro SS. Immunological specificity and mechanism
of action of IgG lupus anticoagulant.Blood 1987;70:69-76.
Pengo V, Biasiolo A, Fior MG. Autoimmune antiphospholipid antibodies are directed
against a cryptic epitope expressed when 2-glycoprotein I is bound to a suitable surface.
Thromb Haemost 1995;73:29-34.
Pengo V, Biasiolo A, Brocco T, Tonetto S, Ruffatti A. Autoantibodies to phospholipid
binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies.
Thromb Haemost 1996;75:721-4.
Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia
M, Ciavarella N, Devoto G, Berrettini M, Musolesi S. Bleeding complications of oral
anticoagulant treatment: an inception-cohort, prospective collaboratory study (ISCOAT).
Lancet 1996;348:423-28.
Pengo V, Zasso A, Barbero F, Banzato A, Nante G, Parissenti L, John N, Noventa F,
Dalla Volta S. Effectiveness of fixed mini-dose warfarin in the prevention of
thromboembolism and vascular death in nonrheumatic atrial fibrillation. Am J Cardiol
1998;82:433-7.
Pengo V, Brocco T, Biasiolo A, Rampazzo P, Carraro P, Zamarchi R. Procoagulant effect
of anti--2 Glycoprotein I antibodies with Lupus Anticoagulant activity.
Blood 1999;94:3814-9.
Palareti G, Hirsh J, Legnani C, Manotti C, D’Angelo A, Pengo V, Moia M, Guazzaloca G,
Musolesi S, Coccheri S. Oral anticoagulation treatment in the elderly: a nested,
prospective, case-control study.
2
Arch Inten Med 2000;160:470-81.
Pengo V, Lensing AWA, Prins M, Marchiori A, Davidson B, Biasiolo A, Pegoraro C, Iliceto
S, Prandoni P. High incidence of symptomatic chronic pulmonary hypertension after
symptomatic pulmonary embolism. N Engl J Med 2004;250:2257-64.
Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V, Ghirarduzzi A,
Pattacini C, Testa S, Lensing AW, Tripodi A; PROLONG Investigators.
D-dimer testing to determine the duration of anticoagulation therapy.
N Engl J Med. 2006 Oct 26;355(17):1780-9.
Amadeus Investigators, Bousser MG, Bouthier J, Büller HR, Cohen AT, Crijns H, Davidson
BL, Halperin J, Hankey G, Levy S, Pengo V, Prandoni P, Prins MH, Tomkowski W, TorpPedersen C, Wyse DG.Comparison of idraparinux with vitamin K antagonists for
prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label,
non-inferiority trial. Lancet. 2008 Jan 26;371(9609):315-21.
Pengo V, Cucchini U, Denas G, Erba N, Guazzaloca G, La Rosa L, De Micheli V, Testa S,
Frontoni R, Prisco D, Nante G, Iliceto S; Italian Federation of Centers for the Diagnosis of
Thrombosis and Management of Antithrombotic Therapies (FCSA).
Standardized low-molecular-weight heparin bridging regimen in outpatients on oral
anticoagulants undergoing invasive procedure or surgery: an inception cohort
management study. Circulation 2009;119:2920-7.
Pengo V, Noventa F, Denas G, Pengo MF, Gallo U, Grion AM, Iliceto S, Prandoni P.
Long-term use of vitamin K antagonists and incidence of cancer: a population-based
study. Blood. 2011;117:1707-9.
Pengo V, Ruffatti A, Legnani C, Testa S, Fierro T, Marongiu F, De Micheli V, Gresele P,
Tonello M, Ghirarduzzi A, Bison E, Denas G, Banzato A, Padayattil Jose S, Iliceto S.
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk
antiphospholipid antibody profile: a multicenter prospective study. Blood. 2011;118:4714-8.
Pengo V, Crippa L, Falanga A, Finazzi G, Marongiu F, Palareti G, Poli D, Testa S, Tiraferri
E, Tosetto A, Tripodi A, Manotti C; Italian Federation of Thrombosis Centers.
3
Questions and answers on the use of dabigatran and perspectives on the use of other new
oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian
Federation of Thrombosis Centers (FCSA). Thromb Haemost. 2011 Nov;106(5):868-76.
Pengo V. Laboratory tests during direct oral anticoagulant treatment? Yes.
Intern Emerg Med. 2013 Aug;8(5):371-2.
Pengo V, Ruffatti A, Del Ross T, Tonello M, Cuffaro S, Hoxha A, Banzato A, Bison E,
Denas G, Bracco A, Padayattil Jose S.
Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid
antibody profile. J Thromb Haemost. 2013 Aug;11(8):1527-31.
Pengo V, Marongiu F; Members of the Steering Committee of the Italian Federation of
Thrombosis Centers FCSA. Phase III studies on novel oral anticoagulants for stroke
prevention in atrial fibrillation: a look beyond the excellent results: a reply to a rebuttal.
J Thromb Haemost. 2013 Jun;11(6):1205-6.
Pengo V, Banzato A, Denas G, Jose SP, Bison E, Hoxha A, Ruffatti A.
Correct laboratory approach to APS diagnosis and monitoring.
Autoimmun Rev. 2013 Jun;12(8):832-4.
Pengo V, Banzato A, Bison E, Bracco A, Denas G, Ruffatti A.
What have we learned about antiphospholipid syndrome from patients and
antiphospholipid carrier cohorts? Semin Thromb Hemost. 2012 Jun;38(4):322-7.
Associate Editor: Internal and Emergency Journal since 2011
4
5